Brief Biederman Report: ADD Medications and Scan Research
Last night spent a delightful evening with Joseph Biederman, MD, Director of Research at Mass General for Child Psychopharmacology and Professor as Harvard, clearly one of the most influential researchers in child psychiatry today. His presentation included numerous scan reports, specifically more fMRI, and demonstrated repeatedly what we have been talking about in previous posts regarding our findings with SPECT at Amen, DC. In a word, regarding scans and neurophysiology, we register considerable findings of agreement. Additional note: Biederman is one of the lead investigators who identified Bipolar Disorder in children, and has suggested specific treatment strategies.
His presentation affirmed that stimulant meds are the treatment of choice for ADD, and that not using meds appropriately is one of the most serious issues present in our current practice. He affirmed with scan evidence that stimulants clearly improve prefrontal cortical functioning.
Further, as an aside, he affirmed his own opinion that long acting stimulant meds deserve to be downgraded from the control of Schedule 2. I have heard from some friends in Washington that the FDA is considering changes in that regard. Dr Biederman made it clear that he didn’t feel he could tell the FDA what to do, but agreed with my own position that some changes should be made in regards to the controls on stimulants.
Biederman made it clear, as many in academia have, that he thinks Daniel Amen uses scans without sufficient evidence, and hates Amen’s use of the term “ring of fire” for bipolar evidence in scans. I think the term he used regarding Amen was “charlatan.” Biederman wants nuclear medicine psychiatrists to wait until researchers agree amongst themselves about specific scan findings. I wondered later if he feels the same way about the SPECT shop in UCLA that recently opened with much fanfare, almost like they were first!
I discussed my three years of experience with Amen in some detail, having seen personally about 1000-1200 patients and reviewed >1000 more, that scans are useful clinically and predictable. Scans make significant differences in treatment strategies and show excellent documentation of comorbid conditions. Our discussion was engaging and positive, though clear differences continue.
I agreed with his point regarding Amen’s consistent and pervasive use of the term “Ring of Fire,” and never used it on any of my own reports, as it is less scientific, more evocative, and does nothing to endear the scientific naysayers who loom in the periphery. “Ring of Fire” becomes an easy target, and does nothing to encourage effective discussion. My choice for that same finding: diffuse cortical hyperperfusion. This term is already in use with nuclear med docs.
It was a privilege to spend an evening with Dr Biederman, and will keep you posted as our conversation develops. I don’t think I will be able to get Biederman together with Amen soon, but hope to facilitate continued discussions with these divergent views.
Digitally available now at Nook, Kindle, Barnes and Noble.
ADHD Medication Rules – PDF For Your Desktop
ADHD Medication Rules | Paying Attention To The Meds For Paying Attention – Kindle Version









